Mark D. Mannie

2.2k total citations
67 papers, 1.7k citations indexed

About

Mark D. Mannie is a scholar working on Immunology, Molecular Biology and Oncology. According to data from OpenAlex, Mark D. Mannie has authored 67 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 57 papers in Immunology, 11 papers in Molecular Biology and 11 papers in Oncology. Recurrent topics in Mark D. Mannie's work include T-cell and B-cell Immunology (44 papers), Immunotherapy and Immune Responses (39 papers) and Immune Cell Function and Interaction (33 papers). Mark D. Mannie is often cited by papers focused on T-cell and B-cell Immunology (44 papers), Immunotherapy and Immune Responses (39 papers) and Immune Cell Function and Interaction (33 papers). Mark D. Mannie collaborates with scholars based in United States and Philippines. Mark D. Mannie's co-authors include Paula Y. Arnold, Thomas M. Buttke, Paul Sandstrom, Philip Y. Paterson, Dhaval M. Patel, D.C. U'Prichard, Alan D. Curtis, Thomas J. McConnell, George Flouret and Lori Blanchfield and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Journal of Immunology and PLoS ONE.

In The Last Decade

Mark D. Mannie

67 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Mark D. Mannie United States	22	1.1k	500	167	134	119	67	1.7k
Cristina Ulivieri Italy	23	825 0.8×	649 1.3×	295 1.8×	98 0.7×	80 0.7×	64	1.7k
Shigeru Negoro Japan	19	465 0.4×	471 0.9×	215 1.3×	150 1.1×	97 0.8×	49	1.2k
David J. Shuster United States	19	749 0.7×	525 1.1×	297 1.8×	41 0.3×	109 0.9×	29	1.6k
Julie Carman United States	19	772 0.7×	441 0.9×	287 1.7×	102 0.8×	55 0.5×	32	1.4k
Sharon H. Jackson United States	16	847 0.8×	530 1.1×	188 1.1×	47 0.4×	149 1.3×	25	1.5k
Ursula Bommhardt Germany	25	1.0k 1.0×	766 1.5×	356 2.1×	59 0.4×	49 0.4×	40	2.0k
Yumi Tohyama Japan	24	603 0.6×	722 1.4×	114 0.7×	54 0.4×	76 0.6×	46	1.8k
Douglas A. Carlow Canada	22	1.1k 1.0×	547 1.1×	395 2.4×	37 0.3×	122 1.0×	36	1.9k
Roel C. van der Veen United States	19	690 0.6×	254 0.5×	149 0.9×	224 1.7×	58 0.5×	29	1.2k
Alexey A. Belogurov Russia	21	440 0.4×	703 1.4×	144 0.9×	193 1.4×	323 2.7×	111	1.4k

Countries citing papers authored by Mark D. Mannie

Since Specialization

Citations

This map shows the geographic impact of Mark D. Mannie's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark D. Mannie with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark D. Mannie more than expected).

Fields of papers citing papers by Mark D. Mannie

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark D. Mannie. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark D. Mannie. The network helps show where Mark D. Mannie may publish in the future.

Co-authorship network of co-authors of Mark D. Mannie

This figure shows the co-authorship network connecting the top 25 collaborators of Mark D. Mannie. A scholar is included among the top collaborators of Mark D. Mannie based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark D. Mannie. Mark D. Mannie is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Curtis, Alan D., et al.. (2019). A GMCSF-Neuroantigen Tolerogenic Vaccine Elicits Systemic Lymphocytosis of CD4+ CD25high FOXP3+ Regulatory T Cells in Myelin-Specific TCR Transgenic Mice Contingent Upon Low-Efficiency T Cell Antigen Receptor Recognition. Frontiers in Immunology. 9. 3119–3119. 10 indexed citations

Wilkinson, Daniel, et al.. (2017). Partial CD25 Antagonism Enables Dominance of Antigen-Inducible CD25high FOXP3+ Regulatory T Cells As a Basis for a Regulatory T Cell-Based Adoptive Immunotherapy. Frontiers in Immunology. 8. 1782–1782. 15 indexed citations

Mannie, Mark D. & Alan D. Curtis. (2013). Tolerogenic vaccines for Multiple Sclerosis. Human Vaccines & Immunotherapeutics. 9(5). 1032–1038. 19 indexed citations

Mannie, Mark D., et al.. (2012). Cytokine-Neuroantigen Fusion Proteins as a New Class of Tolerogenic, Therapeutic Vaccines for Treatment of Inflammatory Demyelinating Disease in Rodent Models of Multiple Sclerosis. Frontiers in Immunology. 3. 255–255. 21 indexed citations

Mannie, Mark D.. (2010). Autoimmunity and asthma: The dirt on the hygiene hypothesis. PubMed. 1(2). 123–128. 1 indexed citations

Mannie, Mark D., et al.. (2009). Experimental Autoimmune Encephalomyelitis in Lewis rats: IFN-β Acts As a Tolerogenic Adjuvant for Induction of Neuroantigen-Dependent Tolerance. The Journal of Immunology. 182(9). 5331–5341. 16 indexed citations

Rehm, Kristina E., et al.. (2009). Vaccinia virus decreases major histocompatibility complex (MHC) class II antigen presentation, T‐cell priming, and peptide association with MHC class II. Immunology. 128(3). 381–392. 29 indexed citations

Mannie, Mark D., et al.. (2007). IL-2/Neuroantigen Fusion Proteins as Antigen-Specific Tolerogens in Experimental Autoimmune Encephalomyelitis (EAE): Correlation of T Cell-Mediated Antigen Presentation and Tolerance Induction. The Journal of Immunology. 178(5). 2835–2843. 16 indexed citations

Mannie, Mark D., et al.. (2006). Cytokine–neuroantigen fusion proteins: New tools for modulation of myelin basic protein (MBP)-specific T cell responses in experimental autoimmune encephalomyelitis. Journal of Immunological Methods. 319(1-2). 118–132. 8 indexed citations

10.

Mannie, Mark D., et al.. (2004). MHC class II biosynthesis by activated rat CD4+ T cells: development of repression in vitro and modulation by APC-derived signals. Cellular Immunology. 230(1). 33–43. 6 indexed citations

11.

Walker, Mindi & Mark D. Mannie. (2001). T cell recognition of rat myelin basic protein as a TCR antagonist inhibits reciprocal activation of antigen-presenting cells and engenders resistance to experimental autoimmune encephalomyelitis. European Journal of Immunology. 31(6). 1894–1899. 4 indexed citations

12.

Mannie, Mark D., et al.. (2001). MHC Class-II-Restricted Antigen Presentation by Myelin Basic Protein-Specific CD4+ T Cells Causes Prolonged Desensitization and Outgrowth of CD4− Responders. Cellular Immunology. 212(1). 51–62. 21 indexed citations

13.

Arnold, Paula Y. & Mark D. Mannie. (1999). Vesicles bearing MHC class II molecules mediate transfer of antigen from antigen-presenting cells to CD4+ T cells. European Journal of Immunology. 29(4). 1363–1373. 80 indexed citations

14.

Arnold, Paula Y., et al.. (1997). Antigen presentation by T cells: T cell receptor ligation promotes antigen acquisition from professional antigen‐presenting cells. European Journal of Immunology. 27(12). 3198–3205. 64 indexed citations

15.

Judge, Susan I. V., et al.. (1997). Potassium channel blockers inhibit adoptive transfer of experimental allergic encephalomyelitis by myelin-basic-protein-stimulated rat T lymphocytes. Journal of Biomedical Science. 4(4). 169–178. 12 indexed citations

16.

Mannie, Mark D., et al.. (1996). T-Helper Lymphocytes Specific for Myelin Basic Protein: Low-Density Activation Prolongs a Postactivation Refractory Phase Marked by Decreased Pathogenicity and Enhanced Sensitivity to Anergy. Cellular Immunology. 172(1). 108–117. 9 indexed citations

17.

Mannie, Mark D., et al.. (1994). T-Helper Lymphocytes Specific for Myelin Basic Protein: Activation-Induced Refractoriness of IL-2 Production Pathways Augments an Anti-CD4-Mediated Proliferative Deficit. Cellular Immunology. 154(2). 484–497. 6 indexed citations

18.

Mannie, Mark D., et al.. (1993). A Unique Costimulatory Pathway Defined with T Cell Hybridomas Specific for Myelin Basic Protein: Third Party Costimulators Restrict Antigenic Responses in Time and Space. Cellular Immunology. 147(1). 25–40. 2 indexed citations

19.

Mannie, Mark D.. (1991). A unified model for T cell antigen recognition and thymic selection of the T cell repertoire. Journal of Theoretical Biology. 151(2). 169–192. 31 indexed citations

20.

Mannie, Mark D., Philip Y. Paterson, David W. Thomas, & RODERICK NAIRN. (1990). Distinct accessory cell requirements define two types of rat T cell hybridomas specific for unique determinants in the encephalitogenic 68-86 region of myelin basic protein.. The Journal of Immunology. 144(2). 440–450. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact